We also demonstrated the antitumor effect of these chimeric antigen receptor T cells in melanoma and colorectal subcutaneous models, indicating that poliovirus receptor targeting chimeric antigen receptor T cells might also serve as a potential therapy for other solid tumors that overexpress poliovirus receptor. This evidence concerns the gene PVR and melanoma.